Global Software as a Medical Device (SaMD) Market, By Type (Cloud-based, On Premise), Application (Screening and Diagnosis, Monitoring and Alerting, Chronic Disease Management) - Industry Trends and Forecast to 2031.
Software as a Medical Device (SaMD) Market Analysis and Size
As per the recent data approximately 6.2 million adults over the age of 20 are newly diagnosed with heart failure. The incidence of heart failure increases with age, and it is more common among older adults. Heart failure is a leading cause of hospitalization among people aged 65 and older. The incidence rates can vary by race and ethnicity, with some groups having a higher risk of developing heart failure.
Data Bridge Market Research analyses that the global software as a medical device (SaMD) market which was USD 1.32 billion in 2023, expected to reach up to USD 5.73 billion by 2031, and is expected to undergo a CAGR of 20.13% during the forecast period. This indicates the market value. “Cloud-based” dominates the type segment of the global software as a medical device (SaMD) market owing to the growing demand for better methods for management of patient’s data. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, and Pricing in USD
|
|
Segments Covered
|
Type (Cloud-based, On Premise), Application (Screening and Diagnosis, Monitoring and Alerting, Chronic Disease Management)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa
|
|
Market Players Covered
|
MindMaze (Switzerland), Siemens Healthneers (Germany), Biofourmis (U.S.), Digital Diagnostics Inc. (U.S.), Silicon & Software Systems Ltd. (Ireland), BrightInsight, Inc. (U.S.), Arterys (U.S.), Medtronic (Ireland), Viz.ai, Inc. (U.S.), iSchemaView, Inc. (U.S.), Medtronic (Ireland), Abbott (U.S.), Oracle (U.S.), 4S Information Systems Ltd. (India), Axis Clinical Software, Inc. (U.S.), CV Medical Software (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Software as a Medical Device (SaMD) refers to software that is intended to be used for medical purposes, without the need for any additional hardware components. SaMD is designed to perform medical functions, such as diagnosing, treating, or preventing diseases, monitoring or managing patient conditions, or supporting healthcare professionals in their decision-making processes. The technological advancements in software and increased accessibility to personal healthcare systems is the major driving factor in the market.
Global Software as a Medical Device (SaMD) Market Dynamics
Drivers
- Increasing Demand for Remote and Personalized Healthcare
The growing need for remote and personalized healthcare services has led to the adoption of SaMD solutions. These software-based medical devices allow patients to monitor their health conditions from home, receive personalized treatment recommendations, and communicate with healthcare professionals remotely, thereby improving access to healthcare and enhancing patient outcomes.
- Growing Partnerships and Collaborations
Collaboration between technology companies, healthcare providers, and pharmaceutical companies is driving the development and adoption of SaMD. Partnerships enable the integration of SaMD with existing healthcare systems, electronic health records, and medical devices, facilitating seamless data exchange and interoperability.
Opportunities
- Expansion of Telehealth and Remote Patient Monitoring
The COVID-19 pandemic has accelerated the adoption of telehealth and remote patient monitoring solutions. SaMD plays a crucial role in enabling remote consultations, monitoring patient conditions, and providing personalized healthcare services. The opportunity lies in developing and enhancing SaMD solutions that can seamlessly integrate with telehealth platforms, offer advanced monitoring capabilities, and provide real-time data analysis for remote patient management.
- Personalized Medicine and Precision Healthcare
SaMD has the potential to enable personalized medicine and precision healthcare by leveraging data analytics and artificial intelligence. SaMD solutions can analyze large volumes of patient data, including genetic information, medical history, and real-time monitoring data, to provide personalized treatment recommendations, predict disease progression, and optimize patient outcomes. The opportunity lies in developing sophisticated SaMD algorithms that can effectively analyze and interpret complex patient data, leading to more accurate diagnoses, tailored treatment plans, and improved patient outcomes.
Restraints/Challenges
- Rigid Regulatory Challenges
While regulations are necessary to ensure the safety and efficacy of SaMD, navigating the complex regulatory landscape can be a significant challenge for companies. Compliance with regulatory requirements, such as obtaining market approvals and maintaining adherence to changing regulations, can be time-consuming and costly. Companies need to invest in regulatory expertise and resources to ensure compliance, which can slow down the development and commercialization of SaMD solutions.
- Data Privacy and Security Concerns
SaMD relies heavily on the collection, storage, and analysis of sensitive patient data. Ensuring the privacy and security of this data is crucial to maintain patient trust and comply with data protection regulations. However, the increasing sophistication of cyber threats poses challenges in safeguarding patient data from unauthorized access, data breaches, and cyber-attacks. Companies developing SaMD solutions need to invest in robust data security measures, encryption protocols, and data governance frameworks to mitigate these risks and protect patient privacy.
This global software as a medical device (SaMD) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global software as a medical device (SaMD) market contact Data Bridge Market Research for an analyst brief, our team will help you make an informed market decision to achieve market growth.
Global Software as a Medical Device (SaMD) Market Scope
The global software as a medical device (SaMD) market is segmented on the basis of type and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Cloud-based
- On Premise
Application
- Screening and Diagnosis
- Monitoring and Alerting
- Chronic Disease Management
Global Software as a Medical Device (SaMD) Market Regional Analysis/Insights
The global software as a medical device (SaMD) market is analyzed and market size insights and trends are provided by country, type, and application as referenced above.
The countries covered in the global software as a medical device (SaMD) market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa.
North America is the region which dominates the global software as a medical device (SaMD) market because of the strong base of healthcare facilities, the strong presence of major players in the market, the extraordinary healthcare infrastructure, and the large pool of patients.
Asia-Pacific region is expected to witness significant growth during the forecast period of 2024 to 2031 due to the increase in government initiatives to promote healthcare, the rising health awareness among the people and growing demand for advanced medical technology for diagnosis and treatment procedures, and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global software as a medical device (SaMD) market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the global software as a medical device (SaMD) market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the global software as a medical device (SaMD) market.
Competitive Landscape and Global Software as a Medical Device (SaMD) Market Share Analysis
The global software as a medical device (SaMD) market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the global software as a medical device (SaMD) market.
Some of the major players operating in the global software as a medical device (SaMD) market are:
- MindMaze (Switzerland)
- Siemens Healthneers (Germany)
- Biofourmis (U.S.)
- Digital Diagnostics Inc. (U.S.)
- Silicon & Software Systems Ltd. (Ireland)
- BrightInsight, Inc. (U.S.)
- Arterys (U.S.)
- Medtronic (Ireland)
- Viz.ai, Inc. (U.S.)
- iSchemaView, Inc. (U.S.)
- Medtronic (Ireland)
- Abbott (U.S.)
- Oracle (U.S.)
- 4S Information Systems Ltd. (India)
- Axis Clinical Software, Inc. (U.S.)
- CV Medical Software (U.S.)
SKU-